Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Interim Management Statement

10 Nov 2014 07:00

RNS Number : 5259W
Kingspan Group PLC
10 November 2014
 

Kingspan Group Plc

Interim Management Statement

 

10 November 2014

 

Kingspan Group plc, the global leader in high performance insulation and building envelopes, today issues the following Interim Management Statement, with trading information for the period from 1 July to 30 September 2014.

 

Sales in the nine month period to 30 September were €1.39bn, up 5% on the prior year (+5% constant currency). A solid sales performance was also recorded in the third quarter with revenue up 7% (+5% constant currency) compared to the same period in 2013.

Insulated Panels revenue in the first nine months increased by 9% (+9% constant currency), and by 8% (+7% constant currency) in the third quarter. The UK continued to perform well with encouraging activity across most building segments. After a sluggish second quarter sales performance, Mainland Europe remained weak through the third quarter reflecting somewhat of an abatement in German market activity. The pace of sales growth in North America improved in the third quarter helped by a strong order book as we entered the second half. Order intake also showed a significant improvement over prior year. Activity in Australasia continued the strong trend evident in the first half.

Insulation Board revenue in the first nine months was up 3% (+1% constant currency) compared with the same period last year, and ahead by 6% in quarter three (+2% constant currency). The UK sales performance was positive through the third quarter, and Mainland European sales were relatively stable overall year on year. Further progress in market conversion was evident in Australia during the third quarter.

Environmental revenue in the first nine months was ahead of last year by 1% (-2% constant currency) and by 3% (-3% constant currency) in the third quarter, continuing on the path of relative stabilisation seen earlier in the year.

Access Floors revenue in the first nine months was 4% behind the same period last year (-4% constant currency). Sales in the third quarter were ahead by 11% (+8% constant currency) with continuing momentum evident in UK office construction activity and an improvement in the US relative to a weak first half.

 Net debt at the end of September 2014 was €107.7m, €39.1m lower than at the same point in 2013. The fourth quarter is a seasonally cash generative period and this would indicate net debt levels by year end in the region of €140m after taking account of the acquisitions of Pactiv Insulation (North America) and PAL (UAE). These insulation board businesses were separately acquired in October for a combined consideration of €77m.The relative optimism that prevailed earlier in the year appears to have waned in recent months, particularly in Europe. Whilst our business continues to perform solidly, we nonetheless are mindful of what are currently more tempered 2015 economic forecasts, and remain focused on driving the Kingspan proposition, whatever the macro climate.

The fourth quarter of 2013 was particularly strong for the Group. Notwithstanding that, and with this seasonally important and often variable period to come, we expect to deliver a full-year trading profit in the region of €144m (+17% versus 2013).

 

For further information contact:

 

Gene Murtagh, Chief Executive Officer Tel: +353 (0) 42 9698000

 

Geoff Doherty, Chief Financial Officer Tel: +353 (0) 42 9698000

 

Douglas Keatinge, Murray Consultants Tel: +353 (0) 1 4980300

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBRBDBGUGBGSR
Date   Source Headline
10th Nov 20102:56 pmRNSHolding(s) in Company
1st Nov 20104:07 pmRNSTotal Voting Rights
23rd Aug 20107:00 amRNSHalf Yearly Report
12th Aug 20102:33 pmRNSInterim Results Notification
3rd Aug 201010:03 amRNSTotal Voting Rights
29th Jul 20103:30 pmRNSDirectorate Change
1st Jul 20107:00 amRNSBlocklisting Interim Review
29th Jun 20109:41 amRNSHolding(s) in Company
23rd Jun 20105:49 pmRNSHolding(s) in Company
15th Jun 20104:23 pmRNSHolding(s) in Company
17th May 201010:16 amRNSHolding(s) in Company
13th May 20105:29 pmRNSDirectorate Change
13th May 201012:38 pmRNSResult of AGM
13th May 20107:00 amRNSInterim Management Statement
5th May 201012:19 pmRNSTotal Voting Rights
15th Apr 20102:30 pmRNSDirector Disclosure Update
13th Apr 201012:46 pmRNSDirector/PDMR Shareholding
13th Apr 201011:48 amRNS2009 Annual Report, Notice of AGM and Proxy
1st Apr 20108:33 amRNSTotal Voting Rights
24th Mar 20105:49 pmRNSAnnual Information Update
15th Mar 201010:22 amRNSHolding(s) in Company - Replacement
11th Mar 20105:40 pmRNSHolding(s) in Company
10th Mar 20104:52 pmRNSDirector/PDMR Shareholding
3rd Mar 20102:37 pmRNSDirector/PDMR Shareholding
2nd Mar 201010:03 amRNSDirector/PDMR Shareholding
1st Mar 20107:00 amRNSFinal Results
14th Jan 201011:22 amRNSNotice of Results
6th Jan 201011:25 amRNSBlocklisting Interim Review
21st Dec 200910:56 amRNSDirector/PDMR Shareholding
14th Dec 20094:10 pmRNSAcquisition
1st Dec 20099:30 amRNSTotal Voting Rights
16th Nov 20097:00 amRNSInterim Management Statement
2nd Nov 20099:32 amRNSTotal Voting Rights
6th Oct 20093:08 pmRNSHolding(s) in Company
24th Aug 20097:00 amRNSHalf Yearly Report
4th Aug 200912:48 pmRNSNotice of Results
4th Aug 20099:32 amRNSHolding(s) in Company
4th Aug 20099:27 amRNSHolding(s) in Company
10th Jul 20093:21 pmRNSHolding(s) in Company
1st Jul 200910:00 amRNSBlocklisting Interim Review
30th Jun 200911:26 amRNSHolding(s) in Company
12th Jun 20097:55 amRNSDirectorate Change
10th Jun 200912:55 pmRNSHolding(s) in Company
10th Jun 200912:50 pmRNSDirector/PDMR Shareholding
15th May 20092:31 pmRNSHolding in Company
14th May 200912:02 pmRNSDirectorate Change
14th May 200912:02 pmRNSResult of AGM
14th May 20097:00 amRNSInterim Management Statement
7th May 200911:11 amRNSHolding(s) in Company
14th Apr 20095:18 pmRNSAnnual Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.